Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Johnsson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Science (London, England : 1979)|August 1, 2002
Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertensionMikael Ekholm, N Håkan Wallén, Hans Johnsson, et al.
British Journal of Haematology|January 31, 2013
A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitorShu He, Hans Johnsson, Michal Zabczyk, et al.
Lakartidningen|February 26, 2008
[Blood plasma as a drug. National evidence-based therapeutic guidelines are missing]Jan Palmblad, Hans Johnsson, Michael Lagerkranser, et al.
Lakartidningen|January 14, 2015
[More with atrial fibrillation, anticoagulants since the coming of NOAK ]Tomas Forslund, Mia von Euler, Hans Johnsson, et al.
Lakartidningen|October 31, 2018
[Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs]Paul Hjemdahl, Frieder Braunschweig, Margareta Holmström, et al.
Scandinavian Cardiovascular Journal : SCJ|March 11, 2003
A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as gold standardTage Nilsson, Mårten Söderberg, Gunilla Lundqvist, et al.
Seminars in Thrombosis and Hemostasis|April 2, 2011
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopeniaRiitta Lassila, Jovan P Antovic, Elina Armstrong, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Science (London, England : 1979)|August 1, 2002
Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertensionMikael Ekholm, N Håkan Wallén, Hans Johnsson, et al.
British Journal of Haematology|January 31, 2013
A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitorShu He, Hans Johnsson, Michal Zabczyk, et al.
Lakartidningen|February 26, 2008
[Blood plasma as a drug. National evidence-based therapeutic guidelines are missing]Jan Palmblad, Hans Johnsson, Michael Lagerkranser, et al.
Lakartidningen|January 14, 2015
[More with atrial fibrillation, anticoagulants since the coming of NOAK ]Tomas Forslund, Mia von Euler, Hans Johnsson, et al.
Lakartidningen|October 31, 2018
[Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs]Paul Hjemdahl, Frieder Braunschweig, Margareta Holmström, et al.
Scandinavian Cardiovascular Journal : SCJ|March 11, 2003
A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as gold standardTage Nilsson, Mårten Söderberg, Gunilla Lundqvist, et al.
Seminars in Thrombosis and Hemostasis|April 2, 2011
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopeniaRiitta Lassila, Jovan P Antovic, Elina Armstrong, et al.
Pageof 2